Click to view our statement on Accessibility
Back
Events

2024 Distressed Investing Conference

04 December 2024

Foley & Lardner LLP is a sponsor/co-chair of the 2024 Distressed Investing Conference, taking place on December 4, 2024, at the Harmonie Club in New York at 4 E 60th St., New York, NY 10022. Harold Kaplan is a featured speaker, and Mark Hebbeln is moderating the presentation “Liability Management – Bankruptcy Litigation: Go Wesco Young Man.”

Once a year, the top industry experts gather together to discuss the latest topics and trends in the distressed investing industry. This value-packed event will feature special presentations from keynote speakers, live panel discussions with industry experts, and networking with other insolvency professionals. Join us for:

  • A gathering of the top distressed investing professionals
  • Special presentations from keynote speakers
  • Live panel discussions with industry experts
  • Networking sessions

To register, please use this link.

People

Harold L. Kaplan

Partner

Chicago 312.832.4393

Mark F. Hebbeln

Partner

Chicago 312.832.4394

Related Insights

View All Posts
20 December 2024 Health Care Law Today

GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024 Manufacturing Industry Advisor

Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment

The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024 Health Care Law Today

HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape

The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.